Maine Cannabis Recalls Are Rising: What the Testing Fight Means for Patients
Maine cannabis recalls are rising as regulators and growers debate testing and contamination in medical and adult-use markets. Nearly 25 product strains have faced recalls or advisories since fall 2024, mainly due to mold, yeast, or pesticide concerns.…
Australia’s Medical Cannabis Regulation at Eight Years: Rapid Growth, Persistent Gaps
Australian medical cannabis regulation has seen rapid growth from 2016 to 2024, with prescriptions rising dramatically. Despite this, persistent gaps remain in cost, access, and prescriber education. This review highlights key challenges and lessons from…
Virginia Lawmakers Push Back on Governor’s Cannabis Amendments (Newsletter: April 15, 2026)
Virginia cannabis regulation updates are creating uncertainty for patient access to medical cannabis. Lawmakers are pushing back on gubernatorial amendments, impacting clinical practice. These regulation updates highlight the need for clinicians to…
LA Ballot Measure Proposes Taxing Illegal Cannabis Shops Amid Safety Concerns
The cannabis tax impact on patient safety is a critical concern in the LA ballot measure proposing to tax illegal cannabis shops. Unregulated products pose risks due to contamination and lack of testing. This policy could affect patient access to safe…
CATHAROS Launches Germany’s Local Marketplace for Medical Cannabis
Germany medical cannabis access is evolving with the launch of a new local marketplace platform. This development aims to improve patient access and healthcare delivery within Germany's regulated framework. The platform connects patients, providers, and…
Debating Medical Marijuana Oversight | newscentermaine.com
Medical marijuana oversight is crucial for ensuring product safety and quality control. Regulatory frameworks affect clinical predictability for patients using medical cannabis. This article discusses the challenges and importance of oversight in medical…
Medical Cannabis Commission Approves Cultivators, Manufacturing Standards Unclear
The 2026 cannabis manufacturing standards remain unclear despite approval of cultivators by the Medical Cannabis Commission. This regulatory gap impacts product quality and patient safety. Clinicians must navigate these challenges carefully to ensure…
11 a.m. Fastcast: Rockford Cannabis Business Reopens Amid Sentencing
The cannabis business reopening impact in Rockford affects patient access to medical cannabis products. Regulatory compliance and local dispensary operations are critical for continuity of care. Understanding these factors helps clinicians and patients…
Alabama’s 1st Medical Cannabis Dispensary Plans to Open Next Month
Alabama medical cannabis dispensary opening represents a milestone for patients with qualifying conditions. This development expands access to regulated cannabis medicine in Alabama. Patients and clinicians now have new options for treatment under the…
Uncertainty Clouds State’s Current Authority to Test Medical Cannabis – Maine Morning Star
Maine's medical cannabis regulatory framework uncertainty affects the state's authority to conduct product testing. This creates potential gaps in quality assurance for cannabis medicines reaching patients. Clinicians should be aware of these challenges…